LifeStance Health Group (NASDAQ:LFST) Major Shareholder Silversmith Partners Gp, Llc Sells 3,592,357 Shares

LifeStance Health Group, Inc. (NASDAQ:LFST) major shareholder Silversmith Partners Gp, Llc sold 3,592,357 shares of the business’s stock in a transaction dated Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the completion of the sale, the insider owned 14,324,197 shares in the company, valued at approximately $72,623,678.79. This trade represents a 20.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

LifeStance Health Group Price Performance

NASDAQ LFST opened at $5.55 on Friday. The stock’s 50-day moving average price is $4.67 and its two-hundred day moving average price is $6.01. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.19. The company has a market cap of $2.16 billion, a PE ratio of -111.00 and a beta of 1.13. LifeStance Health Group, Inc. has a 1 year low of $3.74 and a 1 year high of $8.61.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.02. The firm had revenue of $345.31 million for the quarter, compared to the consensus estimate of $345.05 million. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The business’s revenue for the quarter was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.06) EPS. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, analysts predict that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on LFST. UBS Group boosted their price objective on LifeStance Health Group from $8.50 to $9.00 and gave the stock a “buy” rating in a report on Friday, August 8th. BTIG Research began coverage on LifeStance Health Group in a report on Friday, July 25th. They set a “buy” rating and a $8.00 price objective on the stock. Finally, Wall Street Zen upgraded LifeStance Health Group from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, LifeStance Health Group currently has an average rating of “Moderate Buy” and an average target price of $8.50.

Institutional Investors Weigh In On LifeStance Health Group

Several large investors have recently made changes to their positions in LFST. Parcion Private Wealth LLC bought a new stake in shares of LifeStance Health Group in the 1st quarter valued at approximately $15,670,000. Dimensional Fund Advisors LP grew its stake in shares of LifeStance Health Group by 87.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company’s stock valued at $25,977,000 after buying an additional 1,643,390 shares in the last quarter. Bank of America Corp DE grew its stake in shares of LifeStance Health Group by 280.1% in the 2nd quarter. Bank of America Corp DE now owns 1,767,051 shares of the company’s stock valued at $9,136,000 after buying an additional 1,302,140 shares in the last quarter. Jacobs Levy Equity Management Inc. bought a new stake in shares of LifeStance Health Group in the 1st quarter valued at approximately $7,932,000. Finally, Qube Research & Technologies Ltd lifted its holdings in LifeStance Health Group by 90.5% in the 2nd quarter. Qube Research & Technologies Ltd now owns 2,455,027 shares of the company’s stock worth $12,692,000 after purchasing an additional 1,166,045 shares during the last quarter. Institutional investors own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.